Roche Holding AG (ROP.SW) — Quality & forensics
As of 2026-10-24 — refreshed nightly. Closelooknet readings from an investment research diary, not ratings or advice.
The Closelooknet module scores
- Valuation 56
- Quality 84
- Growth 21
- Balance sheet 60
- Cash quality 53
- Capital allocation 47
- Momentum 79
Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.
Financial forensics — the academic screens
Sits in the safe zone (above 2.99). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.
Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.
Screens reported earnings for statistical manipulation patterns — below the −1.78 manipulation-risk threshold. A screen, not an accusation.
Continue: the ROP.SW chart & overview
FAQ · from the current data · as of 2026-10-24
Quick answers
What is Roche Holding AG's Closelooknet quality reading?
The composite reads 56/100 across 7 modules, as of 2026-10-24: valuation 56, quality 84, growth 21, balance sheet 60, cash quality 53, capital allocation 47, momentum 79. Closelooknet scores are research diary readings, not ratings or investment advice.
What is Roche Holding AG's Altman Z-Score?
5.02, which sits in the safe zone (above 2.99) as of 2026-10-24. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.
What is Roche Holding AG's Piotroski F-Score?
6 of 9, as of 2026-10-24. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.
What does Roche Holding AG's Beneish M-Score indicate?
-2.81 — below the −1.78 manipulation-risk threshold, as of 2026-10-24. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.
Related in the Closelooknet universe
- BION.SW BB Biotech AGsector
- HALO Halozyme Therapeutics Incsector
- ONC BeiGene, Ltd.sector
- DXCM DexCom Incsector
- LLY Eli Lilly and Companysector
- UCB.BR UCB SAsector
- ANN.AU Ansell Ltdsector
- ARGX.BR Argen-Xsector
- MEDP Medpace Holdings Incsector
- ARGX argenx NV ADRsector
- HQY HealthEquity Incsector
- ORNAV.HE Orion Oyj Asector
- ORNBV.HE Orion Oyj Bsector
- ROVI.MC Laboratorios Farmaceuticos ROVIsector
- RIGL Rigel Pharmaceuticals Incsector
- FPH.AU Fisher & Paykel Healthcare Corporation Ltdsector
- GMED Globus Medicalsector
- REGN Regeneron Pharmaceuticals Incsector
- SECT-B.ST Sectra AB (publ)sector
- VEEV Veeva Systems Inc Class Asector